May 9, 2018 / 11:05 AM / 14 days ago

BRIEF-Seres Therapeutics Reports Qtrly Loss Per Share Of $0.69

May 9 (Reuters) - Seres Therapeutics Inc:

* SERES THERAPEUTICS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES OPERATIONAL UPDATES

* SERES THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.69

* SERES THERAPEUTICS INC - QTRLY TOTAL REVENUE $4 MILLION VERSUS $3 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below